Drugs of Abuse/Toxicology News on diagnostic systems for drugs of abuse and toxicology. IVitalize Acquires Genetic Testing Laboratory Geneus Health Geneus offers a genetic test to identify potential genetic predisposition to reward deficiency syndrome, a primary marker for addiction. 908 Devices Using IPO Proceeds to Drive Adoption of Miniature Mass Spec Tech Premium The company is looking to grow uptake of its products in a variety of life science markets ranging from toxicology testing to biopharma research. Prescient Medicine, Erasmus MC Partner to Study Opioid Addiction Risk Test Prescient offers a test that is designed to determine an individual's risk of opioid addiction by analyzing 16 genes in the brain's reward pathway. Quidel Touts Product Pipeline Despite Revenue Headwinds Premium The firm plans to launch 10 new products next year, but analysts were cautious about Quidel's prospects moving forward. GWAS Links Cannabis Use to Mental Health Traits, Risk-Taking Behavior Researchers associated with the International Cannabis Consortium and 23andMe found a causal relationship between schizophrenia and cannabis use. Jan 18, 2018 AACC Drug Testing Guidelines Take Steps Toward Reducing Excessive Drug Panel Testing Oct 5, 2017 Prescient Medicine Acquires Pharmacogenomics Lab PGxL Laboratories Oct 3, 2017 UTHealth Team Wins $2.6M Grant to Study Gene-Environment Interactions in Cocaine Use Aug 29, 2017 Prescient Medicine Launches Addiction Risk Test Developed With AutoGenomics Premium Nov 4, 2016 Alere Q3 Revenues Down 4 Percent as Would-Be Acquirer Abbott Sues for Breach of Contract Sep 6, 2016 Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales Aug 17, 2016 Alere Reports 6 Percent Dip in Q1 Revenues Despite Strong Rapid Influenza MDx Sales Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.